Exagen News

Exagen Announces Campaign for Lupus Awareness Month

CARLSBAD, Calif., May 06, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (NASDAQ:XGN), a leading provider of autoimmune testing solutions, today announced, in recognition of Lupus Awareness Month, the launch of a campaign

GlobeNewswireMay 6 16:05 ET

Exagen to Announce First Quarter 2024 Results on May 13, 2024

CARLSBAD, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, will release financial results for the quarter ended March 31, 2024, before

GlobeNewswireApr 30 16:05 ET

Exagen: Brian Birk, Ebetuel Pallares, Wendy Johnson to Step Down From Board, Effective June 10 >XGN

Exagen: Brian Birk, Ebetuel Pallares, Wendy Johnson to Step Down From Board, Effective June 10 >XGN

Dow JonesApr 26 08:32 ET

Exagen: Scott Kahn Joining Board >XGN

Exagen: Scott Kahn Joining Board >XGN

Dow JonesApr 26 08:32 ET

Exagen Reducing Size of Board to Seven Directors From Nine >XGN

Exagen Reducing Size of Board to Seven Directors From Nine >XGN

Dow JonesApr 26 08:31 ET

Express News | Exagen Inc. Announces Changes to the Board of Directors

ReutersApr 26 08:30 ET

The Exagen Inc. (NASDAQ:XGN) Annual Results Are Out And Analysts Have Published New Forecasts

As you might know, Exagen Inc. (NASDAQ:XGN) just kicked off its latest yearly results with some very strong numbers. It looks like a positive result overall, with revenues of US$53m beating forec

Simply Wall StMar 22 14:55 ET

Analyst Estimates: Here's What Brokers Think Of Exagen Inc. (NASDAQ:XGN) After Its Annual Report

Yahoo FinanceMar 21 06:25 ET

Exagen Inc.'s (NASDAQ:XGN) 28% Dip In Price Shows Sentiment Is Matching Revenues

Exagen Inc. (NASDAQ:XGN) shareholders won't be pleased to see that the share price has had a very rough month, dropping 28% and undoing the prior period's positive performance. The drop over the la

Simply Wall StMar 20 06:19 ET

Exagen Full Year 2023 Earnings: Beats Expectations

Yahoo FinanceMar 20 06:16 ET

Buy Rating Affirmed for Exagen on Strong Financials and Strategic Growth Initiatives

TipRanksMar 20 05:56 ET

Exagen Inc. (NASDAQ:XGN) Q4 2023 Earnings Call Transcript

Yahoo FinanceMar 19 09:37 ET

Exagen's Challenge: Strengthening Financial Controls to Restore Confidence and Secure Growth

TipRanksMar 19 02:00 ET

Q4 2023 Exagen Inc Earnings Call

Yahoo FinanceMar 19 01:55 ET

Exagen's Strong Q4 Performance and Positive Outlook Justify Buy Rating

TipRanksMar 18 19:05 ET

Earnings Call Summary | Exagen(XGN.US) Q4 2023 Earnings Conference

The following is a summary of the Exagen Inc. (XGN) Q4 2023 Earnings Call Transcript:Financial Performance:Exagen reported a record full-year revenue of $52.5 million for 2023, a 15% increase over 202

moomoo AIMar 18 13:30 ET · Conference Call

Exagen Reports Q4 Results

Seeking AlphaMar 18 11:27 ET

Canopy Growth, Outlook Therapeutics, Immuneering Among Healthcare Movers

Seeking AlphaMar 18 10:00 ET

Earnings Flash (XGN) EXAGEN Reports Q4 Revenue $13.8M, Vs. Street Est of $11.6M

08:45 AM EDT, 03/18/2024 (MT Newswires) -- Earnings Flash (XGN) EXAGEN Reports Q4 Revenue $13.8M, vs. Street Est of $11.6M

MT NewswiresMar 18 08:45 ET

Express News | Exagen Shares Are Trading Higher After the Company Reported Better Than Expected Q4 FY2023 Earnings and Issued FY2024 Guidance

Moomoo 24/7Mar 18 08:14 ET